HONG KONG SAR – Media OutReach – 15 July 2021 – ACT Genomics Holdings Co. Ltd. (“ACT Genomics” or “the Group“) announced today that its NGS testing-focused operation and laboratory at the Hong Kong Science Park has been accredited by the Accreditation Committee of the College of American Pathologists (CAP). With two already CAP accredited laboratories in Taipei and Kanagawa, Japan, and now the latest addition, the Group has notably strengthened NGS testing services and R&D capacity.

The CAP accredited ACT Genomics HK Laboratory, which started operation at the Hong Kong Science Park in July, 2019, made it through stringent CAP tests in the accreditation process. And, external quality assurance tests will be conducted twice a year hereafter to ensure the laboratory meets required standards at all times.

The laboratory has a dual NGS testing platform from Illumina and Thermo Fisher. Spanning 3,500 square feet, it is run by a team of eight qualified laboratory technicians, including one PhD, three with master’s degree, and four registered Medical Laboratory Technologists. The newly accredited laboratory can play a major supportive role in the region.

Apart from boosting the capacity of the Group for providing services and support, the three laboratories will continue to pursue research projects, helping develop new products to enrich the Group’s product portfolio and enable it to seize other business opportunities.

According to the facility’s Director Alfa Bai, PhD (Dr. rer. nat.), the accreditation is substantive, in the 18-month accreditation process, on top of on-site visit to the laboratory, CAP also assigned tests to the team – altogether 20 external quality assurance reference samples and over a thousand achieved research samples for testing at the laboratory – to confirm the accuracy and consistency of its work.

Bai says the CAP accreditation process is more stringent than the others of its kind, requiring not only very high management standard, but also meticulous technical and operational details. Though there had been a delay because of the Covid-19 pandemic, the accreditation came within two years the laboratory opened. In the past, samples of Hong Kong patients were sent to the Taipei laboratory for testing, and now the results could be known sooner. The Taipei laboratory will have a lighter load and for the Group, it will have a bigger capacity to serve cancer patients in the region.

Hua Chien Chen, PhD, Chief Executive Officer of ACT Genomics Holdings Co. Ltd. says, “Our laboratory in Hong Kong is fully functional for NGS testing. Although it is not required by law to obtain international accreditation to conduct clinical tests for patients, ACT Genomics is determined to seek the CAP recognition that it may ensure the laboratory maintains the highest professional standards. With our three laboratories in full-swing, we can serve more patients and are well-backed up in delivering professional and timely services. We will also be able to collect more cancer-related data of Asians to add to the data we have collected over the years, to the benefit of R&D of cancer treatment.”

The CAP Laboratory Accreditation Program, recognized by the U.S. federal government, was launched in the early 1960s, as being equal-to or more-stringent-than government inspection programs.

The CAP accreditation process is designed to ensure a laboratory affords the highest standard of care for all patients it serves. Inspectors from CAP examine a laboratory’s records and quality control of procedures in the preceding two years, and laboratory staff qualifications, equipment, facilities, safety program and record, and overall management audits are carried out on an ongoing basis.

For the photo of ACT Genomics Hong Kong Laboratory Earns CAP Accreditation, please refer to the link: https://bit.ly/3xH2xDL

About ACT Genomics Holdings Co. Ltd.

ACT Genomics® is an innovation-driven cancer solution provider in Asia with offices in Taipei, Hong Kong, Singapore and Tokyo. After setting up our laboratories in Taiwan and Japan, we opened our third laboratory in Asia at Hong Kong Science Park in July 2019. With our Next-Generation Sequencing (NGS) technology, CAP-accredited laboratories, experienced bioinformatics team and proprietary AI algorithms, we provide optimal cancer treatment planning, immunotherapy evaluation, cancer relapse & drug resistance monitoring, as well as cancer risk assessment services to medical professionals.

Our team is specialized in biomarker identification, underlying disease mechanism discovery and genetic alteration exploration. Pharmaceutical communities are also able to benefit from our expertise in identifying targets for drug development, stratifying patients for clinical studies, and delineating drug responses with efficiency and efficacy. We also participate in various international precision medicine biomarker programs, such as the TMB and HRD Harmonization Programs led by FOCR in the United States. Together, we “Turn Genomics into Action”.

#ACTGenomics

KUALA LUMPUR, MALAYSIA – Media OutReach – 15 July 2021 – Easybook.com (Easybook) – Southeast Asia’s leading long-range mobility software provider has just completed a Series-C funding round led by investment firm Emissary Capital (Emissary). The round equaling a total of USD5M features a combination of both new and vendor shares, and will be utilized to bolster Easybook’s already significant presence across the region.

Easybook.com is Southeast Asia’s leading long-range mobility software provider. The business provides ticketing and route management software solutions to bus, train and ferry operators across the region. Operating in Malaysia, Singapore, Indonesia, Vietnam, Myanmar, Cambodia, Laos and Brunei. Easybook currently manages a staggering USD1.6B worth of regional long-range travel inventory in an industry estimated to be worth north of USD11B a year, giving the business a strong market presence and significant room for growth.

The new capital will be utilized to expand the company’s inventory as well as drive revenue through additional monetization strategies. The business will continue its efforts to add to its suite of software solutions including additional functionality in the bus/ferry terminal management space. Easybook will also be making key structural changes to the business by moving its HQ to Malaysia to drive more operational efficiency.

Key pillar to the region’s economy

Long-range travel is a key pillar to the region’s economy. Far too often investors’ attention is focused on air-travel, but for the vast bulk of people, air-travel comes second to buses, trains and ferries. This is especially true for archipelago nations like Indonesia and the Philippines with still developing airport infrastructure. Land and sea travel are industries that have been built on small- to mid-sized operators that don’t have the scale to develop highly integrated software themselves. Easybook is the clear solution for these operators, providing them with an advanced suite of functions. Of the regions estimated 5,000 route operators, the company already services over 1,200 of them. Through these efforts Easybook is focused on digitizing an industry that is the sleeping giant of the region, bringing efficiency to the grassroots of how people travel across Southeast Asia.

Managing Director of Easybook, William Lee said: “We are very happy with the completion of this funding round. The capital from this investment will go a long way in expanding our presence and growing our inventory. This will be key as we line up for an IPO in the coming years. Having a partner like Emissary that brings operational value to the table is what attracted us to the deal. Many investors talk about adding value but there is little substance behind those words. With the Emissary team we felt that was different, they have already begun adding a number of high profile people to the management team”

Erman Akinci – Managing Partner at Emissary stated, “We are very excited about this investment. We have been impressed with what William and the Easybook team have done over the past several years. They have secured what we feel is one of the region’s most valuable travel assets. This deal allows us to get in on an amazing business that has been unfairly affected by COVID-19 and is expected to rebound swiftly as travel restrictions are lifted through 2021 and 2022.”

Easybook plans to utilise the USD5M raised to drive more growth into the business. This will be done by expanding its inventory and developing monetization strategies for the assets that it currently controls. This will be done to move the company towards an IPO in the next 24 to 36 months.

Emissary Capital

Emissary Capital is a Malaysia-based boutique investment firm focusing on ASEAN growth companies. The team is made up of current and ex-founders that have built sizable businesses across Southeast Asia. The firm utilizes an active-management strategy with a key focus on operational value adding. The firm was launched in late 2020 and currently has 200M in AUM.

For more information, visit emissarycapital.com

Easybook.com

Easybook.com is Southeast Asia’s leading long-range mobility software provider. The business provides ticketing and route management solutions to mobility operators across the region. Servicing over 1,200 clients and managing USD1.6B worth of travel inventory, Easybook is Southeast Asia’s grassroots mobility solutions provider.

For more information, visit easybook.com

#longrangemobilitysoftwareprovider #softwareprovider #ticketingandroutemanagement #managementsoftwaresolutions #softwaresolutions #transportationoperators #transportation #newcapital #SoutheastAsia #VentureCapitalFund #growthstagefund #SeriesC #Fundraise #boutique #investmentfirm

SINGAPORE – Media OutReach – 15 July 2021 – HIZERO, a premium home appliances maker, today unveiled its latest revolutionary all-in-one cordless bionic floor cleaner, that offers superior cleaning performance, and other benefits like quiet running and enhanced user ergonomics.

“Powerful yet lightweight, the new HIZERO F803 delivers consumers powerful yet gentle and versatile cleaning of liquids and solids from all hard floor types, leaving surfaces super clean and hygienic,” said HIZERO CEO Sam Li.

In April, the HIZERO F803 all-in-one cordless bionic floor cleaner won the bronze Edison Awards. It was handpicked for the best-of-the-best accolade by 3,000 of the world’s top ranking senior business executives, academics, and innovation professionals.

More than a vacuum cleaner

The HIZERO F803 hard floor cleaner utilises a revolutionary polymer roller head to pick up liquids, dust, and other particles and then seamlessly separates them into separate, waste-specific compartments – leaving behind a clean, air dry floor.

And because its technology is not a vacuum system, the HIZERO F803 reduces the risk of dust particles from laminate and other hard floors being resuspended, which is good news for those suffering breathing conditions sparked by airborne allergens.

HIZERO UltimateClean™ technology differs from traditional vacuum cleaners and mops because it captures dust, allergen particles, and other waste and transports them into specific compartments built into the sleek and slender body of the HIZERO F803, making it a premium choice for people with an allergy or asthma.

The new HIZERO F803 all-in-one cordless bionic floor cleaner harnesses HIZERO UltimateClean™ technology to give consumers a contemporary, hyper efficient, and versatile appliance that mops, sweeps, dries, and self-cleans with greater performance than competitors using traditional wet floor washing technologies.

Key benefits of the HIZERO F803

• Cordless
• Extra-long 60 minute run time from a full charge
• One full charge enables the one-litre water tank to clean 100 square metres of hard floor before recharging is required
• Easy disposal of water from waste separation compartments
• All dust is collected in the dirty water tank; dust is not transferred from floor to air
• Thoughtfully designed to be lightweight and manoeuvrable
• Only 60db — quieter than traditional vacuum cleaners (about 70db and up)

The HIZERO F803 is the latest in the range of state-of-the-art upright HIZERO Bionic Floor cordless hard-floor cleaner. HIZERO harnesses revolutionary bionic technology design approaches to give consumers a truly versatile appliance that sweeps, washes, dries, and self-cleans. Earlier recognition includes the U.S. 2018 VDTA Innovative Cleaning Technology of the Year Award, Malaysia’s HOMEDEC 2017 Innovative Product Prize, and a nomination for the 2019 IHA global innovation award.

The new hard floor cleaner will be rolled out into key markets starting in China, Australia, Malaysia, Singapore and elsewhere in the USA and Europe from mid-2021. The company will also unveil its own HIZERO branded eco-friendly disinfectant liquid for global distribution.

The HIZERO F803 is now available at major departmental stores, specialised home appliance stores and major online platforms like Lazada and Shopee. Recommended retail price is SGD 999.00.

More product images and videos can be found in the press kit.

About HIZERO Technologies CO.,LTD

HIZERO Technologies CO.,LTD founded in 2013, specialises in innovative cleaning technology. Inspired by bionics, HIZERO created the world’s first dual-use and self-cleanable floor cleaner. Inspired by nature, HIZERO makes life simpler.

About VISO Pte Ltd

VISO Pte Ltd, a subsidiary of Visionary Solutions Sdn Bhd, is a distributor that has since established a name for itself as the premier solutions company providing highly effective, premium quality products. We pride ourselves in representing products that actually work!

#HIZERO

AWS recognised G-AsiaPacific’s consistent performance in the implementation and development of AWS cloud solutions in Malaysia and across ASEAN, with a significant annual recurring revenue during the 2H2020 to 1Q2021 period.

KUALA LUMPUR, MALAYSIA – Media OutReach – 15 July 2021 – G-AsiaPacific Sdn Bhd (“G-AsiaPacific”) was named 2021 Amazon Web Services (“AWS”) Consulting Partner of the Year (Malaysia) at the recent AWS Partner Summit, in recognition of G-AsiaPacific’s consistent contribution and robust growth in the development of AWS cloud solutions for enterprises, corporates, small and medium enterprises (“SMEs”), mid-market companies, and multinational companies (“MNCs”) in Malaysia and across ASEAN.

G-AsiaPacific is a wholly-owned subsidiary of Bursa Malaysia Ace Market-listed company K-One Technology Berhad. G-AsiaPacific and AWS have been collaborating since 2012, when the company was appointed AWS Consulting Partner and AWS Solution Provider. In 2017, G-AsiaPacific became AWS Advanced Consulting Partner. This was followed by joining the AWS Public Sector Partner Program in 2018.

Chief Executive Officer (CEO) of G-AsiaPacific, Mark Goh Kiang Kiat (吴强结), said: “We are honoured to receive this 2021 AWS Consulting Partner of the Year – Malaysia – award. This recognition represents the strong commitment by AWS towards the AWS Partner Network (APN) community. I would like to take this opportunity to thank AWS. We pride ourselves with our commitment in the development and implementation of advanced cloud solutions in various industries including retail, healthcare, media, services, manufacturing, education, and public sector across the ASEAN region.”

“We are committed to helping companies embrace the latest AWS cloud services to transform and scale their business digitally in this new norm, regardless of whether they are big corporates/MNC, SMEs, or mid-sized companies. This award could help propel our business growth across the ASEAN region,” Goh added.

“At AWS ASEAN, we consider our partners to be an extension of our team. Never has this shared obsession with serving our customers been more visible than over the last twelve months, where we have seen so many ASEAN partners go above and beyond on behalf of our customers,” said Conor McNamara, Managing Director, AWS ASEAN.

“The AWS ASEAN Partner Awards is an opportunity for us to recognize the exceptional contributions of AWS Partners from across ASEAN. We are humbled by the collective commitment of our partner community and congratulate all award winners on this well-deserved recognition.”

During the qualifying period of this award, G-AsiaPacific has seen a significant annual recurring revenue (ARR) growth as the company delivered consistent performance throughout the period.

This is the second award won by G-AsiaPacific since it was appointed as AWS Advanced Consulting Partner in 2017. In 2019, the Company was awarded the AWS Country Partner of the Year – Malaysia. Two awards won by G-AsiaPacific in a span of three years reflects the company’s strong evolvement in delivering business value to customers by leveraging modern cloud development and AWS services.

AWS honours leading partners across the region that help customers drive business innovation. The AWS Partner Award is presented every year to recognise AWS Partners that are constantly building capabilities and specializations to ensure customers success, jointly with AWS.

The AWS Partner Network (APN) is a global community of Partners who leverage AWS to build solutions and services for customers. AWS helps Partners build, market and sell their AWS offerings by providing business, technical, and marketing support. The APN includes independent software vendors (“ISVs”) and systems integrators (“Sis”) around the world, with APN Partner participation in the ASEAN region growing significantly over the past 12 months.

#GAsiaPacific